What makes cancer stem cell markers different
作者： Uwe Karsten , Steffen Goletz
关键词:
摘要: Since the cancer stem cell concept has been widely accepted, several strategies have proposed to attack cells (CSC). Accordingly, markers are now preferred therapeutic targets. However, problem of tumor specificity not disappeared but shifted another question: how can be distinguished from normal cells, or more specifically, do CSC differ markers? A hypothesis is which might help solve this in at least a subgroup markers. Glycosylation may provide key.
springeropen.com
springer.com
core.ac.uk
paperity.org参考文章(115)
Wei Guo, Joseph L. Lasky, Chun-Ju Chang, Sherly Mosessian, Xiaoman Lewis, Yun Xiao, Jennifer E. Yeh, James Y. Chen, M. Luisa Iruela-Arispe, Marileila Varella-Garcia, Hong Wu, Multi-genetic events collaboratively contribute to Pten -null leukaemia stem-cell formation Nature. ,vol. 453, pp. 529- 533 ,(2008) , 10.1038/NATURE06933
UWE KARSTEN, GÜNTER BUTSCHAK, YI CAO, STEFFEN GOLETZ, FRANZ-GEORG HANISCH, A new monoclonal antibody (A78-G/A7) to the Thomsen-Friedenreich pan-tumor antigen Hybridoma. ,vol. 14, pp. 37- 44 ,(1995) , 10.1089/HYB.1995.14.37
J. Beuth, H. L. Ko, V. Schirrmacher, G. Uhlenbruck, G. Pulverer, Inhibition of liver tumor cell colonization in two animal tumor models by lectin blocking with D-galactose or arabinogalactan. Clinical & Experimental Metastasis. ,vol. 6, pp. 115- 120 ,(1988) , 10.1007/BF01784842
Y. Cao, U. Karsten, Gerd Otto, P. Bannasch, Expression of MUC1, Thomsen-Friedenreich antigen, Tn, sialosyl-Tn, and α2,6-linked sialic acid in hepatocellular carcinomas and preneoplastic hepatocellular lesions Virchows Archiv. ,vol. 434, pp. 503- 509 ,(1999) , 10.1007/S004280050375
Kiyotaka Okuno, Yasuaki Shirayama, Hiroaki Ohnishi, Katsuhiko Yamamoto, Masatoshi Ozaki, Takeshi Hirohata, Ichizo Nakajima, Masayuki Yasutomi, A successful liver metastasis model in mice with neuraminidase treated colon 26 Surgery Today. ,vol. 23, pp. 795- 799 ,(1993) , 10.1007/BF00311622
Katja Engelmann, Hongmei Shen, Olivera J. Finn, MCF7 Side Population Cells with Characteristics of Cancer Stem/Progenitor Cells Express the Tumor Antigen MUC1 Cancer Research. ,vol. 68, pp. 2419- 2426 ,(2008) , 10.1158/0008-5472.CAN-07-2249
Kenneth O. Lloyd, Joy Burchell, Valery Kudryashov, Beatrice W. T. Yin, Joyce Taylor-Papadimitriou, Comparison of O-Linked Carbohydrate Chains in MUC-1 Mucin from Normal Breast Epithelial Cell Lines and Breast Carcinoma Cell Lines: DEMONSTRATION OF SIMPLER AND FEWER GLYCAN CHAINS IN TUMOR CELLS Journal of Biological Chemistry. ,vol. 271, pp. 33325- 33334 ,(1996) , 10.1074/JBC.271.52.33325
D Mizrak, M Brittan, MR Alison, CD133: molecule of the moment. The Journal of Pathology. ,vol. 214, pp. 3- 9 ,(2008) , 10.1002/PATH.2283
Yi Cao, Peter Stosiek, Georg F. Springer, Uwe Karsten, Thomsen-Friedenreich-related carbohydrate antigens in normal adult human tissues: a systematic and comparative study Histochemistry and Cell Biology. ,vol. 106, pp. 197- 207 ,(1996) , 10.1007/BF02484401
Christophe Ginestier, Min Hee Hur, Emmanuelle Charafe-Jauffret, Florence Monville, Julie Dutcher, Marty Brown, Jocelyne Jacquemier, Patrice Viens, Celina G. Kleer, Suling Liu, Anne Schott, Dan Hayes, Daniel Birnbaum, Max S. Wicha, Gabriela Dontu, ALDH1 is a marker of normal and malignant human mammary stem cells and a predictor of poor clinical outcome Cell Stem Cell. ,vol. 1, pp. 555- 567 ,(2007) , 10.1016/J.STEM.2007.08.014